Loading...
Lung Diagnostics Will Face Regulatory Delays While Modest Progress Unfolds
AnalystLowTarget's Fair Value
US$1.50
403.3% overvalued intrinsic discount04 Sep
US$7.55
1Y
-78.7%7D
-6.6%1Y
-78.7%7D
-6.6%You can edit this narrative until Aug 12 10:57 PM. Then, changes will post as Updates.